Gilead Sciences

Gilead Sciences Inc (GILD): Today's Featured Drugs Laggard
The Street
Sat, 03/16/13 - 10:43 am
Gilead Sciences
This Week in Biotech
Motley Fool
Sun, 02/24/13 - 02:20 pm
Roche
Immunogen
Repros Therapeutics
Chelsea Therapeutics
Gilead Sciences
Vivus
Gilead Issues a Voluntary Recall of One Lot of Vistide® (Cidofovir Injection) Due to Presence of Particulate Matter
Yahoo/BusinessWire
Sat, 02/16/13 - 11:33 am
Gilead Sciences
Vistide
cytomegalovirus retinitis
HIV
Has Gilead Sciences Become the Perfect Stock?
Motley Fool
Sat, 02/9/13 - 10:54 am
Gilead Sciences
Gilead Sciences Inc: Today's Featured Drugs Winner
The Street
Sat, 02/9/13 - 10:50 am
Gilead Sciences
Gilead Sciences completes acquisition of YM BioSciences
Yahoo/PR Newswire
Sat, 02/9/13 - 10:42 am
Gilead Sciences
YM BioSciences
M&A
Foolish Preview: Gilead Earnings
Motley Fool
Sun, 02/3/13 - 11:41 am
Gilead Sciences
earnings
Gilead Sciences Earnings: An Early Look
Motley Fool
Sat, 02/2/13 - 11:40 am
Gilead Sciences
Analysis: Drug industry bets on new blockbusters in 2013
Reuters
Tue, 01/15/13 - 11:37 am
Roche
GlaxoSmithKline
Eli Lilly
Biogen Idec
Gilead Sciences
Novo Nordisk
2012 Roundup -- HCV Treatments
Motley Fool
Sun, 12/30/12 - 12:15 pm
HCV
Vertex Pharmaceuticals
Merck
Gilead Sciences
Abbott Laboratories
hepatitis C
Achillion
Idenix
JNJ
GSK
Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)
Investopedia
Sat, 12/29/12 - 09:42 am
Celgene Corporation
Regeneron
Gilead Sciences
4 FDA Approvals in 1 Day
Motley Fool
Wed, 12/26/12 - 09:30 am
FDA
drug approvals
Roche
Tamiflu
Gilead Sciences
Gattex
NPS Pharmaceuticals
Alexza
Adasuve
VariZIG
Cangene
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
European Commission approves oral granule formulation of Gilead Viread
Pharmaceutical Business Review
Sat, 12/15/12 - 12:57 pm
Gilead Sciences
Viread
HIV
AIDS
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 12/15/12 - 11:33 am
YM BioSciences
Gilead Sciences
M&A
Infinity Pharmaceuticals
Synta Pharmaceuticals
Gilead Sciences' Stock Dividend And What's Behind It
Seeking Alpha
Sat, 12/15/12 - 11:23 am
Gilead Sciences
Gilead to buy YM BioSciences for about $465 million
Reuters
Wed, 12/12/12 - 10:02 am
YM BioSciences
M&A
Gilead Sciences
Invest in the Great Progress of Hepatitis C
Motley Fool
Sat, 12/8/12 - 11:17 am
hepatitis C
Gilead Sciences
sofosbuvir
Medivir
TMC435
ACH-1625
Achillion
Gilead Sciences Leads The Race In Developing A Hepatitis C Pill
Seeking Alpha
Sat, 12/8/12 - 11:04 am
Gilead Sciences
hepatitis C
sofosbuvir
5 Drug Hopefuls That Are Going to Change Your Life: Part 2
Motley Fool
Sat, 11/24/12 - 12:01 pm
Gilead Sciences
sofosbuvir
hepatitis C
Bristol-Myers Squibb
BMS-986094
Idenix
IDX-184
Abbott Laboratories
Achillion
ACH-3102

Pages